GlassScriptPhysician profile
Keith Joseph Basler
NPI 1447592845
$10,642.79
in general payments reported to CMS, 2019-2025
34 companies · $1,680 in 2025
The $1,680 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,672 · 2020: $420 · 2021: $734 · 2022: $1,130 · 2023: $1,874 · 2024: $2,133 · 2025: $1,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,612 · Education: $74.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,612.42 |
| Education | $74.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,422.50 | 2019-2020 | |
| Glaxosmithkline, LLC. | $1,428.98 | 2019-2025 | Trelegy Ellipta, Nucala |
| Neurent Medical Limited | $1,251.60 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Regeneron Healthcare Solutions, INC. | $935.97 | 2020-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $783.98 | 2020-2025 | Fasenra, Tezspire, Airsupra |
| Optinose US, INC. | $570.77 | 2019-2025 | |
| Genzyme Corporation | $480.74 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $308.88 | 2020-2021 | |
| Depuy Synthes Sales INC. | $292.96 | 2023-2025 | Matrixmandible, Na |
| Acclarent, INC | $275.70 | 2022-2023 | Trudi Nav Cable, Relieva Spinplus |
| Kaleo, INC. | $231.44 | 2020-2023 | Auvi-Q |
| Alk-Abello, INC | $225.79 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Aerin Medical INC. | $219.19 | 2022-2025 | |
| Medtronic, INC. | $173.18 | 2024-2025 | Propel |
| Integra Lifesciences Corporation | $150.38 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $119.18 | 2023 | Zenith Spiral-Z |
| Hikma Pharmaceuticals USA | $85.56 | 2022-2023 | Ryaltris |
| Biohaven Pharmaceutical Holding Company LTD. | $77.87 | 2022 | |
| Sanofi-Aventis U.S. LLC | $74.75 | 2023 | |
| Medtronic USA, INC. | $73.24 | 2020 | |
| Pfizer INC. | $65.79 | 2023-2025 | |
| Itamar Medical INC | $61.27 | 2025 | Watchpatone |
| C2dx, INC | $46.16 | 2023 | |
| Organogenesis INC. | $38.31 | 2025 | Novachor |
| Merz Pharmaceuticals, LLC | $38.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.05 | 2019-2022 | |
| Stryker Corporation | $30.32 | 2025 | Xpress Loprofile |
| Phadia US INC. | $29.01 | 2022-2024 | Immunocap |
| Ctl Medical Corporation | $25.00 | 2021 | |
| Smith+Nephew, INC. | $23.87 | 2019 | |
| Genentech USA, INC. | $20.48 | 2019 | |
| Amgen INC. | $20.25 | 2022 | |
| Checkpoint Surgical, INC | $16.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Basler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.